Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Cereno Scientific

5.72 SEK

-1.30 %

Less than 1K followers

CRNO B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cereno Scientific

2019202020212022202320242025
Revenue11.0
growth-%
EBITDA-13.1-15.7-15.0-27.5-44.6-75.6-73.8
EBIT-13.1-15.7-15.0-27.5-44.7-75.8-74.6
Profit before taxes-15.3-16.0-16.3-27.6-48.1-99.5-117.8
Net income-15.3-16.0-16.3-27.6-48.1-99.5-117.8
EPS-0.38-0.40-0.15-0.20-0.21-0.14-0.38
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-119.2 %
EBIT-%-119.2 %
ROE-25.6 %-16.1 %-9.6 %-13.7 %-22.2 %-51.9 %-46.6 %
ROI-23.9 %-14.3 %-9.0 %-12.8 %-16.9 %-24.1 %-29.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.